Hello, Fool! | Login | Signup | My Fool
Jul 23, 2008 5:49 PM ET | Site Changes | Help
Search: Tickers Company Names Players
The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.
View Ticker Page (AZN)
Results 41 - 50 of 50 : 12345
Recs
clu2000 (87.30) Submitted: 10/26/06 2:38 PM : Start Price: $57.49 AZN Score: -11.94
earnings continue to rise, despite one drug not working
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
bearmyx (98.40) Submitted: 5/04/07 6:20 PM : Start Price: $51.73 AZN Score: 4.12
near 52 week lows,
incansun (69.60) Submitted: 6/14/07 6:43 PM : Start Price: $49.50 AZN Score: -9.40
This stock is analogous to the titanic. Bad news when CFO leaves right after a big transaction with MedImmune.
tmorkes (27.39) Submitted: 6/27/07 7:00 PM : Start Price: $50.79 AZN Score: 5.49
Bought it after it dropped from the Medimmune purchase. Should be back up to $60 range in a matter of months.
aaroger (< 20) Submitted: 7/25/07 3:37 PM : Start Price: $52.59 AZN Score: -3.00
65
mhheins (46.23) Submitted: 8/16/07 2:37 AM : Start Price: $43.66 AZN Score: 13.86
suspect, but tremendous potential for growth based in a pipeline that is ever expanding - one very large hurdle - size - they may be too big and need to spin off
mimosapartners (75.59) Submitted: 9/23/07 2:13 PM : Start Price: $47.79 AZN Score: -12.33
Several state AG's; Arkansas for one, have joined in a class action lawsuit that may prove costly for AZN.
chk999longonly (99.28) Submitted: 12/31/07 1:19 PM : Start Price: $41.34 AZN Score: 24.26
This is at a 52 week low.Trading at a cheap (for a pharma) PE ratio of 15 and change, this looks like a bargain.
pilarcity (73.04) Submitted: 1/22/08 5:09 PM : Start Price: $40.92 AZN Score: 11.75
Excellent combination of biotech and pharma portfolios.
JohnyRay (94.17) Submitted: 9/10/06 10:28 PM : Start Price: $57.39 AZN Score: -18.42
AZN has a solid pipeline. Big pharma has had a tough few years in general and will outperform the market over the next 5 years with excellent long-term prospects as world population ages and new drugs are discovered.
Report this Post Replies: 1 | Reply | Permalink
Terms & Conditions
RSS Headlines
Fool UK